GPs demand change to govt’s ‘nonsensical’ glucose monitor funding rules
All patients with type 1 diabetes were made eligible for the subsidised devices this month
The Federal Government should let GPs approve patient access to subsidised continuous glucose monitoring devices now that all 130,000 Australians with type 1 diabetes are eligible, the RACGP says.
Continuous glucose monitoring (CGM) technology lets patients track their glucose levels with fewer fingerprick blood tests, but the devices can cost up to $5000 a year on the private market.
